Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study
- PMID: 38525041
- PMCID: PMC10955169
- DOI: 10.3934/microbiol.2024008
Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study
Abstract
One of the most prevalent malignancies that significantly affects world health is colorectal cancer (CRC). While genetics are involved in a portion of CRC patients, most cases are sporadic. The microbiome composition could be a new source of tumor initiation and progression. This research was conducted to investigate the microbiota composition of CRC patients post colectomy at taxonomic and functional levels. Using a next-generation sequencing approach, using an Illumina Novaseq 6000, the fecal samples of 13 patients were analyzed and the obtained data was subjected to a bioinformatics analysis. The bacterial abundance and uniqueness varied in CRC patients alongside differences in bacterial counts between patients. Bacteroides fragilis, Bacteroides vulgatus, Escherichia coli, and Fusobacterium nucleatum were among the pro-cancerous microorganisms found. Concurrently, bacteria linked to CRC progression were detected that have been previously linked to metastasis and recurrence. At the same time, probiotic bacteria such as Bifidobacterium dentium, Bifidobacterium bifidum, and Akkermansia muciniphila increased in abundance after colectomies. Additionally, numerous pathways were deferentially enriched in CRC, which emerged from functional pathways based on bacterial shotgun data. CRC-specific microbiome signatures include an altered bacterial composition. Our research showed that microbial biomarkers could be more usefully employed to explore the link between gut microbiota and CRC using metagenomic techniques in the diagnosis, prognosis, and remission of CRC, thereby opening new avenues for CRC treatment.
Keywords: CRC; dysbiosis; gut microbiota; metagenomic; tumor biomarker.
© 2024 the Author(s), licensee AIMS Press.
Conflict of interest statement
Conflict of interests: The authors declare that they have no conflict of interests.
Figures




Similar articles
-
Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.J Adv Res. 2023 Oct;52:45-57. doi: 10.1016/j.jare.2022.12.015. Epub 2022 Dec 31. J Adv Res. 2023. PMID: 36596411 Free PMC article. Review.
-
Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.Cancer Med. 2023 Jul;12(14):15720-15735. doi: 10.1002/cam4.6194. Epub 2023 Jun 1. Cancer Med. 2023. PMID: 37260140 Free PMC article.
-
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.Infect Agent Cancer. 2021 Jun 9;16(1):41. doi: 10.1186/s13027-021-00381-4. Infect Agent Cancer. 2021. PMID: 34108031 Free PMC article.
-
Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):305-322. doi: 10.1007/s10096-023-04551-7. Epub 2023 Jan 27. Eur J Clin Microbiol Infect Dis. 2023. PMID: 36703031 Free PMC article.
-
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.Cancers (Basel). 2023 Jan 30;15(3):866. doi: 10.3390/cancers15030866. Cancers (Basel). 2023. PMID: 36765824 Free PMC article. Review.
Cited by
-
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans.Cancer Biol Med. 2025 Mar 12;22(2):93-112. doi: 10.20892/j.issn.2095-3941.2024.0263. Cancer Biol Med. 2025. PMID: 40072039 Free PMC article. Review.
-
Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues.Front Microbiol. 2024 Aug 21;15:1422536. doi: 10.3389/fmicb.2024.1422536. eCollection 2024. Front Microbiol. 2024. PMID: 39234556 Free PMC article.
-
Long-read 16S rRNA amplicon sequencing reveals microbial characteristics in patients with colorectal adenomas and carcinoma lesions in Egypt.Gut Pathog. 2025 Feb 2;17(1):8. doi: 10.1186/s13099-025-00681-9. Gut Pathog. 2025. PMID: 39894814 Free PMC article.
References
-
- Suliman MA, Zamzam ML, Omar AT, et al. Clinicopathological profile of colorectal cancer patients in Suez Canal University Hospitals-Egypt. J Cancer Biol Res. 2020;8:1127.
LinkOut - more resources
Full Text Sources